Home › Funds › Point72 Asset Management › AMLX

Point72 Asset Management position in AMLX

AMYLYX PHARMACEUTICALS INC · Health Care

Latest position (Q2 2026)15.80K sh
Reported value held$283.77K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q2 2022 312.46K $6.02M New
Q3 2022 466.96K $13.14M Add
Q4 2022 2.13M $78.63M Add
Q1 2023 324.80K $9.53M Reduce
Q2 2023 7.11K $153.30K Reduce
Q3 2023 46 $842 Reduce
Q4 2023 2.75M $40.50M Add
Q1 2024 170.00K $482.80K Reduce
Q3 2024 200 $648 New
Q1 2025 916.97K $3.25M New
Q2 2025 4.54M $29.08M Add
Q3 2025 2.79M $37.92M Reduce
Q4 2025 335.00K $4.05M Reduce
Q1 2026 106.53K $1.48M Reduce
Q2 2026 15.80K $283.77K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding AMLX

All AMLX fund holders →